BioAge Labs (BIOA) Interest & Investment Income (2023 - 2026)
BioAge Labs (BIOA) reported Interest & Investment Income of $3.3 million for Q1 2026, down 12.01% on a YoY basis from $3.7 million in Q1 2025, and down 74.83% sequentially from $13.0 million in Q4 2025.
BioAge Labs (BIOA) Interest & Investment Income (2023 - 2026) Analysis & Trends
BioAge Labs (BIOA) has 4 years of Interest & Investment Income data on file, last reported at $3.3 million in Q1 2026.
- For the quarter ending Q1 2026, Interest & Investment Income fell 12.01% year-over-year to $3.3 million; the trailing twelve-month figure through Mar 2026 stood at $16.3 million (up 7423.04% YoY), and the FY2025 full-year result was $13.1 million, changed N/A from the prior year.
- Interest & Investment Income slipped to $3.3 million in Q1 2026, from $13.0 million in the prior quarter.
- In the past five years, Interest & Investment Income ranged from a high of $13.0 million in Q4 2025 to a low of -$5.5 million in Q4 2024.
- A 4-year average of $2.2 million and a median of $1.3 million in 2023 frame the typical range for Interest & Investment Income.
- Across the five-year window, Interest & Investment Income tumbled 1560.16% in 2024 and jumped 334.62% in 2025, its largest moves.
- Tracing BIOA's Interest & Investment Income over 4 years: stood at $379000.0 in 2023, then plunged by 1560.16% to -$5.5 million in 2024, then jumped by 334.62% to $13.0 million in 2025, then plunged by 74.83% to $3.3 million in 2026.
- Business Quant data shows BIOA's Interest & Investment Income at $3.3 million in Q1 2026, $13.0 million in Q4 2025, and $73000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn | - |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn | 32.85 Mn |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn | 41.80 Mn |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn | 28.10 Mn |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn | - |
| 10 | BioAge Labs | 909.51 Mn | 909.51 Mn | -10.37 Mn | 3.27 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.27 Mn |
| Dec 31, 2025 | 12.98 Mn |
| Sep 30, 2025 | 73,000.00 |
| Mar 31, 2025 | 3.71 Mn |
| Dec 31, 2024 | -5.53 Mn |
| Sep 30, 2024 | 2.04 Mn |
| Dec 31, 2023 | 379,000.00 |
| Sep 30, 2023 | 499,000.00 |